About Irmandade da Santa Casa de Misericórdia de Marília
"Missão “Prestar assistência às pessoas de forma a aliviar a dor e diminuir o sofrimento, com dedicação e solidariedade valorizando a vida.” Visão “Ser referência no Estado de São Paulo em qualidade e segurança do cuidado, desenvolvimento organizacional e sustentabilidade econômica e ambiental, até 2025.” Valores “Ética, Acolhimento, Qualidade, Responsabilidade Socioambiental” Negócio “Promoção da saúde”."
Clinical Trials at Irmandade da Santa Casa de Misericórdia de Marília
During the past decade, Irmandade da Santa Casa de Misericórdia de Marília conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Irmandade da Santa Casa de Misericórdia de Marília"
#1 collaborator was "Ministry of Health, Brazil" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Irmandade da Santa Casa de Misericórdia de Marília
According to Clinical.Site data, the most researched conditions in "Irmandade da Santa Casa de Misericórdia de Marília" are
"Acute Coronary Syndrome" (2 trials), "Coronary Artery Disease" (1 trials) and "VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery" (1 trials). Many other conditions were trialed in "Irmandade da Santa Casa de Misericórdia de Marília" in a lesser frequency.
Clinical Trials Intervention Types at Irmandade da Santa Casa de Misericórdia de Marília
Most popular intervention types in "Irmandade da Santa Casa de Misericórdia de Marília" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Antiplatelet Monotherapy" (1 trials), "Apixaban 2.5 mg" (1 trials), "Apixaban placebo" (1 trials), "Double Dose Quadrivalent Influenza Vaccine" (1 trials) and "JNJ-64179375 (Dose to be Determined)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Irmandade da Santa Casa de Misericórdia de Marília
The vast majority of trials in "Irmandade da Santa Casa de Misericórdia de Marília" are
4 trials for "All" genders.
Clinical Trials Status at Irmandade da Santa Casa de Misericórdia de Marília
Currently, there are NaN active trials in "Irmandade da Santa Casa de Misericórdia de Marília".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Irmandade da Santa Casa de Misericórdia de Marília,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Irmandade da Santa Casa de Misericórdia de Marília, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".